NYSE:STVN (Italy)
Business Description
Stevanato Group SPA
NAICS : 339114
SIC : 3841
Via Molinella 17, Piombino Dese, Padua, ITA, 35017
Description
Italy-based Stevanato Group is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. Stevanato's revenue is geographically diversified, with 60% of sales from Europe, the Middle East and Africa (EMEA), 27% in North America, 10% in Asia-Pacific (APAC), and 3% in South America.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.47 | |||||
Equity-to-Asset | 0.6 | |||||
Debt-to-Equity | 0.25 | |||||
Debt-to-EBITDA | 1.01 | |||||
Interest Coverage | 33.82 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 5.6 | |||||
Beneish M-Score | -2.31 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Future 3-5Y EPS without NRI Growth Rate Industry Rank | 7.79 | |||||
Future 3-5Y Total Revenue Growth Rate Industry Rank | 8.25 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 58.4 | |||||
9-Day RSI | 62.14 | |||||
14-Day RSI | 61.37 | |||||
6-1 Month Momentum % | -16.24 | |||||
12-1 Month Momentum % | -25.95 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.11 | |||||
Quick Ratio | 1.64 | |||||
Cash Ratio | 0.83 | |||||
Days Inventory | 96.83 | |||||
Days Sales Outstanding | 67.46 | |||||
Days Payable | 86.51 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.29 | |||||
Dividend Payout Ratio | 0.11 | |||||
Forward Dividend Yield % | 0.29 | |||||
5-Year Yield-on-Cost % | 0.29 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 31.12 | |||||
Operating Margin % | 17.1 | |||||
Net Margin % | 13.57 | |||||
ROE % | 15.78 | |||||
ROA % | 8.79 | |||||
ROIC % | 14.51 | |||||
ROC (Joel Greenblatt) % | 34.08 | |||||
ROCE % | 15.41 | |||||
Years of Profitability over Past 10-Year | 3 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 32.47 | |||||
Forward PE Ratio | 35.78 | |||||
PE Ratio without NRI | 32.47 | |||||
PS Ratio | 4.64 | |||||
PB Ratio | 4.6 | |||||
Price-to-Tangible-Book | 5.09 | |||||
Price-to-Operating-Cash-Flow | 30.54 | |||||
EV-to-EBIT | 23.04 | |||||
EV-to-Forward-EBIT | 27 | |||||
EV-to-EBITDA | 17.02 | |||||
EV-to-Forward-EBITDA | 19.27 | |||||
EV-to-Revenue | 4.4 | |||||
EV-to-Forward-Revenue | 4.88 | |||||
EV-to-FCF | -54.1 | |||||
Price-to-Graham-Number | 2.74 | |||||
Price-to-Net-Current-Asset-Value | 17.3 | |||||
Earnings Yield (Greenblatt) % | 4.33 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NYSE:STVN
Executives
EMBED
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 996.367 | ||
EPS (TTM) ($) | 0.511 | ||
Beta | 0 | ||
Volatility % | 50.16 | ||
14-Day RSI | 61.37 | ||
14-Day ATR ($) | 0.926707 | ||
20-Day SMA ($) | 16.253 | ||
12-1 Month Momentum % | -25.95 | ||
52-Week Range ($) | 13.355 - 29.18 | ||
Shares Outstanding (Mil) | 264.7 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Stevanato Group SPA Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |